To date, a number of clinical trials have shown weight regain after discontinuing GLP-1 drugs. In the STEP 1 trial extension, ...

In the chart below, we highlight the unlikely scenarios needed to ... Lilly have set the bar for efficacy and side effect ...

Eli Lilly and Company ’s LLY stock has risen 21.1% in six months compared with an increase of 10.5% for the industry. The ...

Novo Nordisk stock rose moderately Wednesday after the pharma giant said its new weight-loss drug, amycretin, outperformed blockbuster shot Wegovy in a 12-week study. Please watch the video at ...

For instance, about 15% of people won’t lose any meaningful weight on Eli Lilly’s Zepbound even at the highest dose. “For those who are responders ... “If you were to look at my chart, it would say, ...

Eli Lilly's weight-loss drug Zepbound and diabetes medication Mounjaro are no longer in short supply. That could limit ...

The FDA has removed two of Eli Lilly's in-demand weight-loss and diabetes drugs from its shortage list. Diabetes drug ...